Oxford BioDynamics Plc (OXBOF)
0.0028
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Oxford BioDynamics Cash from Operations (TTM) : -10.10M for March 31, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -10.10M |
| September 30, 2025 | -10.34M |
| March 31, 2025 | -15.01M |
| September 30, 2024 | -13.18M |
| March 31, 2024 | -8.436M |
| September 30, 2023 | -10.28M |
| March 31, 2023 | -9.894M |
| September 30, 2022 | -6.814M |
| March 31, 2022 | -7.455M |
| September 30, 2021 | -8.026M |
| Date | Value |
|---|---|
| March 31, 2021 | -6.252M |
| September 30, 2020 | -4.150M |
| March 31, 2020 | -3.399M |
| September 30, 2019 | -2.676M |
| March 31, 2019 | -2.196M |
| September 30, 2018 | -2.495M |
| March 31, 2018 | -1.814M |
| September 30, 2017 | -1.785M |
| March 31, 2017 | -1.695M |
| September 30, 2016 | -1.873M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Proteome Sciences Plc | -- |
| Ixico Plc | -2.718M |
| ICON plc | 1.083B |
| Champions Oncology, Inc. | -5.564M |
| Silence Therapeutics Plc | -41.79M |